Tai YT - Search Results

1

BAD partly reverses paclitaxel resistance in human ovarian cancer cells.

Strobel T, Tai YT, Korsmeyer S, Cannistra SA. Strobel T, et al. Among authors: tai yt. Oncogene. 1998 Nov 12;17(19):2419-27. doi: 10.1038/sj.onc.1202180. Oncogene. 1998. PMID: 9824152

2

BAX protein expression and clinical outcome in epithelial ovarian cancer.

Tai YT, Lee S, Niloff E, Weisman C, Strobel T, Cannistra SA. Tai YT, et al. J Clin Oncol. 1998 Aug;16(8):2583-90. doi: 10.1200/JCO.1998.16.8.2583. J Clin Oncol. 1998. PMID: 9704707

3

Adenovirus vector-based purging of multiple myeloma cells.

Teoh G, Chen L, Urashima M, Tai YT, Celi LA, Chen D, Chauhan D, Ogata A, Finberg RW, Webb IJ, Kufe DW, Anderson KC. Teoh G, et al. Among authors: tai yt. Blood. 1998 Dec 15;92(12):4591-601. Blood. 1998. PMID: 9845525

4

Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cells.

Chauhan D, Hideshima T, Treon S, Teoh G, Raje N, Yoshihimito S, Tai YT, Li W, Fan J, DeCaprio J, Anderson KC. Chauhan D, et al. Among authors: tai yt. Cancer Res. 1999 Mar 15;59(6):1192-5. Cancer Res. 1999. PMID: 10096546

5

In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.

Tai YT, Strobel T, Kufe D, Cannistra SA. Tai YT, et al. Cancer Res. 1999 May 1;59(9):2121-6. Cancer Res. 1999. PMID: 10232598

6

CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines.

Teoh G, Tai YT, Urashima M, Shirahama S, Matsuzaki M, Chauhan D, Treon SP, Raje N, Hideshima T, Shima Y, Anderson KC. Teoh G, et al. Among authors: tai yt. Blood. 2000 Feb 1;95(3):1039-46. Blood. 2000. PMID: 10648420

7

Isolation and characterization of human multiple myeloma cell enriched populations.

Tai YT, Teoh G, Shima Y, Chauhan D, Treon SP, Raje N, Hideshima T, Davies FE, Anderson KC. Tai YT, et al. J Immunol Methods. 2000 Feb 21;235(1-2):11-9. doi: 10.1016/s0022-1759(99)00199-4. J Immunol Methods. 2000. PMID: 10675753

8

Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.

Hideshima T, Chauhan D, Teoh G, Raje N, Treon SP, Tai YT, Shima Y, Anderson KC. Hideshima T, et al. Among authors: tai yt. Clin Cancer Res. 2000 Mar;6(3):1180-9. Clin Cancer Res. 2000. PMID: 10741750

9

SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells.

Chauhan D, Pandey P, Hideshima T, Treon S, Raje N, Davies FE, Shima Y, Tai YT, Rosen S, Avraham S, Kharbanda S, Anderson KC. Chauhan D, et al. Among authors: tai yt. J Biol Chem. 2000 Sep 8;275(36):27845-50. doi: 10.1074/jbc.M003428200. J Biol Chem. 2000. PMID: 10880513

10

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

Hideshima T, Chauhan D, Shima Y, Raje N, Davies FE, Tai YT, Treon SP, Lin B, Schlossman RL, Richardson P, Muller G, Stirling DI, Anderson KC. Hideshima T, et al. Among authors: tai yt. Blood. 2000 Nov 1;96(9):2943-50. Blood. 2000. PMID: 11049970 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results